2017 Taubman Prize
For Excellence in Translational Medical Science
This award is presented annually by the A. Alfred Taubman Medical Research Institute at the University of Michigan. It is meant to recognize work in the crucial field of translational research being conducted by the clinician-scientist who has done the most to transform laboratory discoveries into clinical applications for patients suffering from disease.
- International scientists are eligible.
- U-M scientists are excluded.
- Self-nomination is permitted.
- The recipient must be available to deliver the keynote speech at the Taubman Institute annual symposium Oct. 21, 2016 in Ann Arbor, Mich.
- Significant contribution to translating basic research findings into medical practice
- The manner in which nominee’s clinical activities connects to his or her laboratory research
Deadline: February 15, 2017
For a nomination to be considered by the selection committee, the following items must be submitted with the completed nomination form:
- A one-page letter of nomination detailing the individual’s extraordinary or sustained contribution to the field of translational research
- The curriculum vitae of the nominee
- The nominee's h factor
- A bibliography of 5 most significant publications
- Two additional letters of support
Electronic submissions are encouraged. Incomplete nominations will not be presented to the nomination committee.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars publish new findings on basal cell cancer
Ophthalmologists Alon Kahana, MD, PhD and Rajesh Rao, MD are trying to pinpoint when the common cancer turns dangerous.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results